×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Aytu BioPharma Inc. (AYTU) NASDAQ

$2.85 - (-)

Market Cap: $17.02M

As of 06/18/24 12:00 AM EDT. Market open.

(AYTU)

Aytu BioPharma Inc. (AYTU)
NASDAQ

$2.85
- (-)

Market Cap: $17.02M

As of 06/18/24 12:00 AM EDT. Market open.

Add to Portfolio

aytu bioscience is a specialty healthcare company focused on developing and commercializing novel products in the field of urology. aytu is initially concentrating on prostate cancer, male premature ejaculation and male infertility and plans to expand into other urological indications for which there are significant medical needs. the company currently markets prostascint®, an fda-approved ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
URL
Address
16200 W County Road 18 E, Colorado, Loveland, 80537-9715.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full Time Employees
112
URL
Address
16200 W County Road 18 E, Colorado, Loveland, 80537-9715.
PRICE CHART FOR AYTU BIOPHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$2.85
Days Range
$2.81 - $2.99
52 week range
$1.38 - $3.50
Volume
1,088
Avg. Volume (30 days)
27,326
Market Cap
$17.02M
Dividend Yield
-
P/E
-
Shares Outstanding
5,972,327
Open
-
Previous Close
$2.85
Days Range
$2.81 - $2.99
52 week range
$1.38 - $3.50
Volume
1,088
Avg. Volume (30 days)
27,326
Market Cap
$17.02M
Dividend Yield
-
P/E
-
Shares Outstanding
5,972,327
FINANCIAL STATEMENTS FOR AYTU BIOPHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR AYTU BIOPHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
PYSZCZYMUKA GREGChief Commerical OfficerJun 16, 2023 Buy$1.8712,00022,42821,935Jun 20, 2023, 08:35 AM
Disbrow Joshua R.Chief Executive OfficerJun 14, 2023 Buy$1.8614,00026,07971,591Jun 15, 2023, 01:52 PM
Disbrow Joshua R.Chief Executive OfficerDec 19, 2022 Buy$0.22112,37125,0471,231,877Dec 21, 2022, 09:17 AM
PYSZCZYMUKA GREGChief Commercial OfficerDec 19, 2022 Buy$0.24100,00024,480182,056Dec 21, 2022, 09:15 AM
Oki Mark KChief Financial OfficerNov 18, 2022 Buy$0.2390,00020,700190,000Nov 28, 2022, 04:30 PM
Disbrow Joshua R.Chief Executive OfficerNov 18, 2022 Buy$0.24222,00052,6141,119,506Nov 28, 2022, 04:30 PM
Disbrow Joshua R.Chief Executive OfficerNov 18, 2022 Option Exercise$0.24222,00052,6141,119,506Nov 21, 2022, 09:30 AM
Oki Mark KChief Financial OfficerNov 18, 2022 Option Exercise$0.2390,00020,700190,000Nov 21, 2022, 09:30 AM
ARMISTICE CAPITAL, LLCDirectorDec 11, 2020 Buy$6.001,333,3348,000,0041,333,334Dec 15, 2020, 07:17 PM
ARMISTICE CAPITAL, LLCDirectorApr 27, 2020 Option Exercise$1.255,000,0006,250,0005,108,921Apr 29, 2020, 08:22 PM
ARMISTICE CAPITAL, LLCDirectorApr 27, 2020 Sale$1.825,108,9219,298,2360Apr 29, 2020, 08:22 PM
Cerecor Inc.10% OwnerApr 15, 2020 Sale$1.5592,777144,0929,713,068Apr 27, 2020, 09:30 AM
ARMISTICE CAPITAL, LLCDirectorMar 10, 2020 Option Exercise$1.301,487,6391,933,93118,119,637Mar 12, 2020, 07:49 PM
ARMISTICE CAPITAL, LLCDirectorMar 10, 2020 Option Exercise$1.1513,310,57415,264,15722,026,802Mar 12, 2020, 07:49 PM
ARMISTICE CAPITAL, LLCDirectorMar 10, 2020 Sale$1.4222,026,80131,200,1232,456,823Mar 12, 2020, 07:49 PM
ARMISTICE CAPITAL, LLCDirectorDec 20, 2019 Buy$0.8826,00022,8807,950,000Dec 23, 2019, 10:10 AM
ARMISTICE CAPITAL, LLCDirectorDec 19, 2019 Buy$0.8552,78844,8707,924,000Dec 23, 2019, 10:10 AM
Disbrow Joshua R.Chief Executive OfficerDec 19, 2019 Buy$0.8955,00048,824525,048Dec 19, 2019, 03:10 PM
ARMISTICE CAPITAL, LLCDirectorOct 30, 2019 Option Exercise$0.882,751,1482,421,0107,871,212Nov 01, 2019, 05:15 PM
Green David AChief Financial OfficerFeb 13, 2019 Option Exercise$1.045,0005,189271,250Feb 15, 2019, 04:45 PM
Green David AChief Financial OfficerDec 21, 2018 Sale$0.813,3302,711266,250Dec 26, 2018, 04:00 PM
Disbrow Joshua R.Chief Executive OfficerMar 06, 2018 Buy$0.45226,105101,747490,949Mar 07, 2018, 04:39 PM
Green David AChief Financial OfficerMar 06, 2018 Buy$0.4566,60029,970141,600Mar 07, 2018, 04:38 PM
Disbrow JarrettChief Operating OfficerMar 06, 2018 Buy$0.45226,105101,747439,490Mar 07, 2018, 04:36 PM
Disbrow JarrettChief Operating OfficerAug 15, 2017 Option Exercise$0.151,666,667250,0002,267,671Aug 22, 2017, 07:58 PM
Disbrow Joshua R.Chief Executive OfficerAug 15, 2017 Option Exercise$0.151,666,667250,0002,296,861Aug 22, 2017, 07:55 PM
Cantrell GaryDirectorFeb 27, 2017 Option Exercise$0.7537,08327,812135,416Mar 08, 2017, 04:40 PM
Gould Gregory AChief Financial OfficerFeb 27, 2017 Option Exercise$0.7566,66650,000340,231Mar 01, 2017, 07:33 PM
DOCKERY CARLDirectorFeb 27, 2017 Option Exercise$0.75416,667312,500837,300Mar 01, 2017, 07:03 PM
Cantrell GaryDirectorFeb 27, 2017 Option Exercise$0.7537,08327,812135,416Mar 01, 2017, 06:47 PM
Disbrow JarrettChief Operating OfficerFeb 27, 2017 Option Exercise$0.75187,500140,625601,004Mar 01, 2017, 06:43 PM
Disbrow Joshua R.Chief Executive OfficerFeb 27, 2017 Option Exercise$0.75187,500140,625630,194Mar 01, 2017, 06:41 PM
Cantrell GaryDirectorNov 02, 2016 Buy$1.5033,33350,00098,333Nov 04, 2016, 04:58 PM
Gould Gregory AChief Financial OfficerNov 02, 2016 Buy$1.5066,66699,999273,565Nov 04, 2016, 04:58 PM
Disbrow JarrettChief Operating OfficerNov 02, 2016 Buy$1.50166,666249,999413,504Nov 04, 2016, 04:57 PM
Disbrow Joshua R.Chief Executive OfficerNov 02, 2016 Buy$1.50166,666249,999442,694Nov 04, 2016, 04:57 PM
DOCKERY CARLDirectorMay 06, 2016 Buy$0.405,000,0002,000,0005,047,591May 16, 2016, 04:17 PM
Disbrow Joshua R.Chief Executive OfficerMay 06, 2016 Buy$0.40250,000100,000403,846May 16, 2016, 04:15 PM
Disbrow JarrettChief Operating OfficerMay 06, 2016 Buy$0.40250,000100,000403,846May 16, 2016, 04:14 PM
Disbrow Joshua R.Chief Executive OfficerJan 20, 2016 Buy$0.65153,846100,000153,846Jan 21, 2016, 04:13 PM
Disbrow JarrettChief Operating OfficerJan 20, 2016 Buy$0.65153,846100,000153,846Jan 21, 2016, 04:11 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
PYSZCZYMUKA GREGChief Commerical Officer06/16/202322,428
Disbrow Joshua R.Chief Executive Officer06/14/202326,079
Disbrow Joshua R.Chief Executive Officer12/19/202225,047
PYSZCZYMUKA GREGChief Commercial Officer12/19/202224,480
Oki Mark KChief Financial Officer11/18/202220,700
Disbrow Joshua R.Chief Executive Officer11/18/202252,614
Disbrow Joshua R.Chief Executive Officer11/18/202252,614
Oki Mark KChief Financial Officer11/18/202220,700
ARMISTICE CAPITAL, LLCDirector12/11/20208,000,004
ARMISTICE CAPITAL, LLCDirector04/27/20206,250,000
ARMISTICE CAPITAL, LLCDirector04/27/20209,298,236
Cerecor Inc.10% Owner04/15/2020144,092
ARMISTICE CAPITAL, LLCDirector03/10/20201,933,931
ARMISTICE CAPITAL, LLCDirector03/10/202015,264,157
ARMISTICE CAPITAL, LLCDirector03/10/202031,200,123
ARMISTICE CAPITAL, LLCDirector12/20/201922,880
ARMISTICE CAPITAL, LLCDirector12/19/201944,870
Disbrow Joshua R.Chief Executive Officer12/19/201948,824
ARMISTICE CAPITAL, LLCDirector10/30/20192,421,010
Green David AChief Financial Officer02/13/20195,189
Green David AChief Financial Officer12/21/20182,711
Disbrow Joshua R.Chief Executive Officer03/06/2018101,747
Green David AChief Financial Officer03/06/201829,970
Disbrow JarrettChief Operating Officer03/06/2018101,747
Disbrow JarrettChief Operating Officer08/15/2017250,000
Disbrow Joshua R.Chief Executive Officer08/15/2017250,000
Cantrell GaryDirector02/27/201727,812
Gould Gregory AChief Financial Officer02/27/201750,000
DOCKERY CARLDirector02/27/2017312,500
Cantrell GaryDirector02/27/201727,812
Disbrow JarrettChief Operating Officer02/27/2017140,625
Disbrow Joshua R.Chief Executive Officer02/27/2017140,625
Cantrell GaryDirector11/02/201650,000
Gould Gregory AChief Financial Officer11/02/201699,999
Disbrow JarrettChief Operating Officer11/02/2016249,999
Disbrow Joshua R.Chief Executive Officer11/02/2016249,999
DOCKERY CARLDirector05/06/20162,000,000
Disbrow Joshua R.Chief Executive Officer05/06/2016100,000
Disbrow JarrettChief Operating Officer05/06/2016100,000
Disbrow Joshua R.Chief Executive Officer01/20/2016100,000
Disbrow JarrettChief Operating Officer01/20/2016100,000
Load More Insider Transactions
FUNDS WITH A POSITION IN AYTU BIOPHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC71,3230.00034%3.48%Other
GEODE CAPITAL MANAGEMENT, LLC34,5630.00001%4.59%Other
BLACKROCK INC.22,7930%No changeOther
CHANGE IN SHARES OUTSTANDING FOR AYTU BIOPHARMA INC
STOCK BUYBACKS FOR AYTU BIOPHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
0.29%
1Q
03/31/2024
09/30/2023
0.94%
2Q
03/31/2024
03/31/2023
48.48%
4Q
03/31/2024
12/31/2022
77.91%
5Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
0.29%
1Q
09/30/2023
0.94%
2Q
03/31/2023
48.48%
4Q
12/31/2022
77.91%
5Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AYTU BIOPHARMA INC
LOADING...